Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billion
October 23, 2023 at 08:36 AM EDT
'Transformative transaction' for Roivant gives Roche rights to promising inflammatory bowel disease treatment
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Events | Directory | Real Estate | Blog | More
|